Diagnostic potential of 0xidative stress indicators in Egyptian type 1 diabetic children and adolescents

Journal of Applied Sciences Research

Volumn 5, Issue 12, 2009, Pages 2524-2534

  Fathy, Shadia A ^a   El Habashy, Safinaz A ^b   Rasheed, Wafaa I ^c   Helmy, Azza S ^a   El Saeed, Gamila S M ^c   Said, Omima M ^c   Youssef, Safaa M ^c  

^a Ain Shams University   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Antioxidants; Lipid peroxidation; Microvascular diabeticcomplications; Protein oxidation; Type 1 diabetes

Indexed keywords

EID: 77955178030     PISSN: 1816157X     EISSN: 1819544X     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Pasupathi, P., V. Chandrasekar and S.U. Kumar, 2009. Evaluation of oxidative stress, enzymatic and non-enzymatic antioxidants and metabolic thyroid hormone status in patients with diabetes mellitus. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 3, 160-165.
2. Ramakrishna, V. and R. Jailkhani, 2007. Evaluation of oxidative stress in IDDM patients. Diagnostic Pathology, 2, 22.
3. Nishikawa, T., D. Eldestein, S. Yamagishi, T. Matsumura and Y. Kaneda, 2000. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature, 404: 787-790.
4. Krzystek-Korpacka, M., B. Salmonowicz, D. Boehm, I. Berdowska, B. Zielinski, E. Patryn, A. Noczynska and A. Gamian, 2008. Diagnostic potential of oxidative stress markers in children and adolescents with type 1 diabetes. Clinical Biochemistry, 41: 48-55.
5. Martin-Gallan, P., A. Carrascosa, M. Gussinye and C. Dominguez, 2003. Biomarkers of diabetesassociated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radical Biology and Medicine, 34: 1563-74.
6. Zwart, L., N. Meerman, M. Commadeur and E. Vermeulen, 1999. Biomarkers of free radical damage,applications in experimental animals and in humans. Free Radical Biology and Medicine, 26(1/2): 202-226.
7. Mera, K., M. Anraku, K. Kitamura, K. Nakajou, T. Maruyama and M. Otagiri, 2005. The structure and function of oxidized albumin in hemodialysis patients: its role in elevated oxidative stress via neutrophil burst. Biochemical and Biophysical Research Communications, 334: 1322-8.
8. Witko-Sarsat, V., M. Friedlander, C. Capeillere-Blandin, T. Nguyen-Khoa, A.T. Nguyen, J. Zingraff, P. Jungers and B. Deschamps, 1996. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney International, 49: 1304-13.
9. Kalousova, M., T. Zima, V. Tesar, Dusilova-S. Sulkova and J. Skrha, 2005. Advanced glycoxidation end products in chronic diseasesclinical chemistry and genetic background. Mutation Research, 579: 37-46.
10. Kalousova, M., J. Skrha and T. Zima, 2002. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiological Research, 51: 597-604.
11. Abou-Seif, M.A. and A. Youssef, 2004. Evaluation of some biochemical changes in diabetic patients. Clinica Chimica Acta, 346: 161-170.
12. Obrosova, I.G., C. Van Hysen, L. Fathallah, X. Cao, D.A. Greene and M.J. Stevens, 2002. An aldose reductase inhibitor reverses early diabetesinduced changes in peripheral nerve function, metabolism and antioxidative defense. Journal of the Federation of American Societies for Experimental Biology, 16: 123-125.
13. Srivatsan, R. S. Das, R. Gadde, K. Manoj-Kumar, S. Taduri, N. Rao, B. Ramesh, A. Baharani, K. Shah, S.C. Kamireddy, G. Priyatham, T.A. Balakumaran, S. Seshadri, A. Kamath and A. Rao , 2009. Antioxidants and Lipid Peroxidation Status in Diabetic Patients with and without Complications. Archives of Iranian Medicine, 12 (2): 121-127.
14. Gil-del Valle, L., de la C.L. Milian, A. Toledo, N. Vilaro, R. Tapanes and M.A. Otero, 2005. Altered redox status in patients with diabetes mellitus type I. Pharmacological Research, 51: 375-80.
15. Bethesda, 1987. Report of the second task force on blood pressure Control in children. 79: 1.
16. Waterlow, J., W. Buzina, J. Keller, M. Lane and J. Janner, 1977. The presentation and use of height and weight data for comparing the nutritional status of groups of children Bulletin of the World Health Organization, 55(4): 489-498.
17. Gabbay, K.H., K. Hasty, K. Hasty, J.L. Breslow, R.C. Ellison, H.F. Bunn and P.M. Gallop, 1977. Glycosylated haemoglobin and long term blood glucose control in diabetes mellitus. Journal of Clinical Endocrinology and Metabolism, 44: 859.
18. Allain, C., C. Lucy, S. Poon, S. Cicely, G. Chen, W. Richmed and C.F. Paul, 1974. Enzymatic determination of total cholesterol. Clinical Chemistry, 20: 470-475.
19. Glick, M.R., K.W. Ryder and S.A. Jackson, 1986. Graphical comparisons of interferences in Clinical Chemistry Instrumentation. Clinical Chemistry, 32: 470-474.
20. Lopez-Virella, M.F., P. Stone, S. Ellis and J. Collwel, 1977. Cholesterol determination in high density lipoprotein by three different methods. Clinical Chemistry, 23(5): 882-884.
21. Steinberg, D., 1981. Metabolism of lipoproteins at the cellular level in relation to atherogenesis. In: Lipoprotin Atherosclerosis and Coronary Heart Disease. Elsevier North Holland., 1(2): 31-34.
22. Mogensen, C.E., 1984. Microalbuminuria predicts clinical proteinuria and early mortality in maturity - onset diabetes. New England Journal of medicine, 310: 356-360.
23. Ohkawa, H., W. Ohishi and K. Yagi, 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical biochemistry, 95: 351-358.
24. Kraus, R.J. and H.E. Ganthen, 1980. Reaction of cyanide with glutathione peroxidase. Biochemical and Biophysical Research Communications, 96 (3): 1116-1122.
25. Bieri, J.G., T.J. Tolliver and G.L. Catignani, 1979. Simultaneous determination of a-tocopherol and retinol in plasma or red cells by high pressure liquid chromatography. American Journal of Clinical Nutrition, 32: 2143-2149.
26. Erciyas, F., F. Taneli, B. Arslan and Y. Uslu, 2004. Glycemic control, oxidative stress, and lipid profile in children with type 1 diabetes mellitus. Archives of Medical Research, 35: 134-40.
27. Hunt, J.V., M.A. Bottoms, K. Clare, J.T. Skamarauskas and M.J. Mitchinson, 1994. Glucose oxidation and low-density lipoproteininduced macrophage ceroid accumulation: possible implications for diabetic atherosclero sis. Biochemical Journal, 300: 243-249.
28. Wittenstein, B., M. Klein, B. Finckh, K. Ullrich and A. Kohlschutter, 2002. Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia. Free Radicals in Biology and Medicine, 33(1): 103-110.
29. Varvarovska, J., J. Racek, F. Stozicky, J. Soucek, L. Trefil and R. Pomahacova, 2003. Parameters of oxidative stress in children with type 1 diabetes mellitus and their relatives. Journal of Diabetes and Its Complications, 17: 7-10.
30. Jyoti, S.M. and Uchita, 2007. Association of poor glycemic control with increased lipid peroxidation and reduced antioxidant vitamin status in diabetic neuropathy. Internet Journal of Endocrinology, 3: 3.
31. Hernández-Marco, R., P. Codoñer-Franch, S.P. Morales, C.C. Villaescusa, L.B. García and V.V. Bellés 2009. Oxidant/antioxidant status and hyperfiltration in young patients with type 1 diabetes mellitus. Pediatric Nephrology, 24: 121-127.
32. Ceriello, A., 1999. Hyperglycemia: the bridge between non-enzymatic gylcation and oxidative stress in the pathogenesis of diabetic complications. Diabetes, Nutrition and Metabolism, 12(1): 42-46.
33. Telci, A., U. Cakatay, R. Kayali, C. Erdogan, Y. Orhan, A. Sivas, et al., 2000. Oxidative protein damage in plasma of type 2 diabetic patients.Horm Metabolic Research, 32: 40-3.
34. Dean, R.T., S. Fu, R. Stocker and M.J. Davies, 1997. Biochemistry and pathology of radicalmediated protein oxidation. Biochemical Journal, 324 (Pt 1) 1-18 (review).
35. Woods, AA., S.M. Linton and M.J. Davies, 2003. Detection of HOCl mediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques. Biochemical Journal, 370: 729-735.
36. Jenkins, A.J., J.D. Best, R.L. Klein and T.J. Lyons, 2004. Lipoproteins, glycoxidation and diabetic angiopathy. Diabetes Metabolism Research and Review, 20: 349-368.
37. Ruiz, C., A. Alegria, R. Barbera, R. Farre and M.J. Lagarda, 1999. Lipid peroxidation and antioxidant activities in patients with type I diabetes mellitus. Scandinavian Journal of Clinical. and Laboratory Investigation, 59: 99-105.
38. Matteucci, E. and O. Giampietro, 2000. Oxidative stress in families of type 1diabetic patients. Diabetes Care, 23: 1182-6.
39. Seckin, D., N. Ilhan, N. Ilhan and S. Ertugrul, 2006. Glycaemic control, markers of endothelial cell activation and oxidative stress in children with type 1diabetes mellitus. Diabetes Research and Clinical Practice, 73: 191-7.
40. Hussein, O.A., Y. Gefen, J.M. Zidan, E.Y. Karochero, A.S. Luder, N.N. Assy, et al., 2007. LDL oxidation is associated with increased blood hemoglobin A1c levels in diabetic patients. Clinica Chimica Acta, 377: 114-8.
41. Martin-Gallán, P., A. Carrascosa, M. Gussinyé and C. Domínguez, 2007. Oxidative stress in childhood type 1 diabetes: Results from a study covering the first 20 years of evolution. Free Radical Research, 41: 919-928.
42. Martin-Gallan, P., A. Carrascosa, M. Gussinye and C. Dominguez, 2005. Estimation of lipoperoxidative damage and antioxidant status in diabetic children: relationship with individual antioxidants. Free Radical Research, 39: 933-42.
43. Levine, B.S., B.J. Anderson, D.A. Butler, J.E. Antisdel, J. Brackett and L.M. Laffel, 2001. Predictors of glycemic control and short-term adverse outcomes in youth with type 1 diabetes. Journal of Pediatric, 139: 197-203.
44. Dominguez, C., E. Ruiz, M. Gussinye and A. Carrascosa, 1998. Oxidative Stress at Onset and in Early Stages of Type 1 Diabetes in Children and Adolescents. Diabetes Care, 21(10): 1736-1742.
45. Frei, B., 1994. Reactive oxygen species and antioxidant vitamins: mechanisms of action. American Journal of Medicine, 97: 5S-13S.
46. Jain, S.K., R. McVie and T. Smith, 2000. Vitamin E supplementation restores glutathione and malondialdehyde to normal concentrations in erythrocytes of type 1 diabetic children. Diabetes Care, 23: 1389-1394